Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
48M
-
Number of holders
-
179
-
Total 13F shares, excl. options
-
46.8M
-
Shares change
-
+1.24M
-
Total reported value, excl. options
-
$1.21B
-
Value change
-
+$32.7M
-
Put/Call ratio
-
1.09
-
Number of buys
-
83
-
Number of sells
-
-92
-
Price
-
$25.96
Significant Holders of BIOLIFE SOLUTIONS INC - Common Stock, par value $0.001 per share (BLFS) as of Q4 2024
215 filings reported holding BLFS - BIOLIFE SOLUTIONS INC - Common Stock, par value $0.001 per share as of Q4 2024.
BIOLIFE SOLUTIONS INC - Common Stock, par value $0.001 per share (BLFS) has 179 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 46.8M shares
of 48M outstanding shares and own 97.43% of the company stock.
Largest 10 shareholders include Casdin Capital, LLC (8.71M shares), BlackRock, Inc. (5.6M shares), Invesco Ltd. (3.24M shares), VANGUARD GROUP INC (2.84M shares), FRED ALGER MANAGEMENT, LLC (1.59M shares), STATE STREET CORP (1.47M shares), MILLENNIUM MANAGEMENT LLC (1.15M shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (910K shares), CRAMER ROSENTHAL MCGLYNN LLC (906K shares), and DIMENSIONAL FUND ADVISORS LP (887K shares).
This table shows the top 179 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.